Fasting Versus Post-Load Plasma Glucose Concentration and the Risk for Future Type 2 Diabetes: Results From The Botnia Study

  1. Muhammad A Abdul-Ghani, MD, PhD (abdulghani{at}uthscsa.edu)1,
  2. Valeriya Lyssenko, M.D., PhD.2,
  3. Tiinamaija Tuomi, MD, PhD2,
  4. Ralph A DeFronzo, MD1 and
  5. Leif Groop, MD2
  1. 1Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, Texas
  2. 2Department of Clinical Sciences, Diabetes and Endocrinology, and Lund University Diabetes Center, Lund University, Malmö, Sweden

    Abstract

    Aim: To assess the efficacy of post-load plasma glucose concentration in predicting future risk of T2DM, compared to prediction models based upon measurement of the fasting plasma glucose (FPG) concentration.

    Research Design and Methods: 2442 subjects from the Botnia Study, who were free of T2DM at baseline, received an OGTT at baseline and after 7-8 years of follow. Future risk for T2DM was assessed with area under the ROC for prediction models based upon measurement of the FPG (i) with or without 1-h PG during the OGTT and (ii) with or without the metabolic syndrome.

    Results: Prediction models based on measurement of the FPG were weak predictors for the risk of future T2DM. Addition of 1-h PG markedly enhanced the prediction the risk of future T2DM. A cut point of 155 mg/dl for the 1-h PG during OGTT and presence of the metabolic syndrome were used to stratify subjects in each glucose tolerance group into low, intermediate and high risk for future T2DM.

    Conclusion: The plasma glucose concentration at 1 hour during the OGTT is a strong predictor of future risk for T2DM and adds to the prediction power of models based upon measurements made during the fasting state. A plasma glucose cut point of 155 mg/dl plus the ATP III criteria for the metabolic syndrome can be used to stratify non-diabetic subjects into low, intermediate and high risk groups.

    Footnotes

      • Received July 8, 2008.
      • Accepted October 30, 2008.